BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31409338)

  • 21. Clinically Significant Cytochrome P450-Mediated Drug-Drug Interactions in Children Admitted to Intensive Care Units.
    Li T; Hu B; Ye L; Feng Z; Huang L; Guo C; Wu X; Tan W; Wang Y; Yang G; Guo C
    Int J Clin Pract; 2022; 2022():2786914. PubMed ID: 36081809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of drug-drug interaction in the ICU - perceptions of intensivists and pharmacists.
    Askari M; Eslami S; Louws M; Dongelmans D; Wierenga P; Kuiper R; Abu-Hanna A
    Stud Health Technol Inform; 2012; 180():716-20. PubMed ID: 22874285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence rate and pattern of clinically relevant potential drug-drug interactions in a large outpatient population of a developing country.
    Nabovati E; Vakili-Arki H; Taherzadeh Z; Saberi MR; Abu-Hanna A; Eslami S
    Res Pharm Sci; 2016; 11(3):233-42. PubMed ID: 27499793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of potential drug-drug interactions in intensive care unit.
    Dagdelen MS; Gulen D; Ceylan I; Girgin NK
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5801-5806. PubMed ID: 34604971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicomponent intervention program to Prevent and Reduce AgItation and phySical rEstraint use in the ICU (PRAISE): study protocol for a multicenter, stepped-wedge, cluster randomized controlled trial.
    Kooken RWJ; Tilburgs B; Ter Heine R; Ramakers B; van den Boogaard M;
    Trials; 2023 Dec; 24(1):800. PubMed ID: 38082351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
    Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
    PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.
    Schneider KL; Kastenmüller K; Weckbecker K; Bleckwenn M; Böhme M; Stingl JC
    Drugs Aging; 2018 Jun; 35(6):559-568. PubMed ID: 29737468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital.
    Farzanegan B; Alehashem M; Bastani M; Baniasadi S
    J Clin Pharmacol; 2015 Feb; 55(2):132-6. PubMed ID: 25369984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential drug-drug interactions in hospitalized pediatric patients with respiratory disorders: a retrospective review of clinically important interactions.
    Hassanzad M; Tashayoie Nejad S; Mahboobipour AA; Salem F; Baniasadi S
    Drug Metab Pers Ther; 2020 Jan; 35(1):. PubMed ID: 32004144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients.
    Wagh BR; Godbole DD; Deshmukh SS; Iyer S; Deshpande PR
    Indian J Crit Care Med; 2019 Apr; 23(4):170-174. PubMed ID: 31130787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, development, implementation, and evaluation of a severe drug-drug interaction alert system in the ICU: An analysis of acceptance and override rates.
    Karajizadeh M; Zand F; Vazin A; Saeidnia HR; Lund BD; Tummuru SP; Sharifian R
    Int J Med Inform; 2023 Sep; 177():105135. PubMed ID: 37406570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescriber perceptions of a near real-time fax alert program for potential drug-drug interactions.
    Armstrong EP; Wang SM; Hines LE; Patel BV; Leslie RS; Malone DC
    J Manag Care Spec Pharm; 2014 May; 20(5):494-500a. PubMed ID: 24761821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations.
    Bakker T; Dongelmans DA; Nabovati E; Eslami S; de Keizer NF; Abu-Hanna A; Klopotowska JE
    J Clin Pharmacol; 2022 Jun; 62(6):706-720. PubMed ID: 34957573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-drug interactions in the intensive care unit: Do they really matter?
    Vanham D; Spinewine A; Hantson P; Wittebole X; Wouters D; Sneyers B
    J Crit Care; 2017 Apr; 38():97-103. PubMed ID: 27883969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).
    Leguelinel-Blache G; Castelli C; Roux-Marson C; Bouvet S; Andrieu S; Cestac P; Collomp R; Landais P; Loulière B; Mouchoux C; Varin R; Allenet B; ; Bedouch P; Kinowski JM
    Trials; 2018 Jan; 19(1):19. PubMed ID: 29310711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriate medication use in Dutch terminal care: study protocol of a multicentre stepped-wedge cluster randomized controlled trial (the AMUSE study).
    van Hylckama Vlieg MAM; Pot IE; Visser HPJ; Jong MAC; van der Vorst MJDL; van Mastrigt BJ; Kiers JNA; van den Homberg PPPH; Thijs-Visser MF; Oomen-de Hoop E; van der Heide A; van der Kuy PHM; van der Rijt CCD; Geijteman ECT
    BMC Palliat Care; 2024 Jan; 23(1):6. PubMed ID: 38172930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prevalence of Drug-Drug Interactions with Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in the Intensive Care Unit.
    Johnston JP; Heavner MS; Liu M; Casal GLH; Akgün KM
    J Pharm Pract; 2023 Apr; 36(2):322-328. PubMed ID: 34587846
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients.
    Tecen-Yucel K; Bayraktar-Ekincioglu A; Yildirim T; Yilmaz SR; Demirkan K; Erdem Y
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1291-1296. PubMed ID: 32996393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety.
    Page N; Baysari MT; Westbrook JI
    Int J Med Inform; 2017 Sep; 105():22-30. PubMed ID: 28750908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.